The Technical Analyst
Select Language :
Becton Dickinson and Co [BDX]

Exchange: NYSE Sector: Healthcare Industry: Medical - Instruments & Supplies

Becton Dickinson and Co Price, Forecast, Insider, Ratings, Fundamentals & Signals

Becton Dickinson and Co is listed at the  Exchange

-1.51% $233.58

America/New_York / 8 mai 2024 @ 16:00


Becton Dickinson and Co: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 67 506 mill
EPS: 4.67
P/E: 50.02
Earnings Date: Aug 01, 2024
SharesOutstanding: 289.01 mill
Avg Daily Volume: 1.337 mill
RATING 2024-05-08
S-
Strong Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Buy
DE: Strong Buy
P/E: Buy
Price To Book: Buy
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
3.24x
Company: PE 50.02 | sector: PE 15.43
PE RATIO: COMPANY / INDUSTRY
1.18x
Company: PE 50.02 | industry: PE 42.42
DISCOUNTED CASH FLOW VALUE
$356.99
(52.84%) $123.41
Date: 2024-05-09
Expected Trading Range (DAY)

$ 229.32 - 237.84

( +/- 1.82%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-05-03 Byington Carrie L Buy 129 Rights to Common Stock Under BD Deferred Compensation Plan
2024-05-03 Jones Christopher Ian Montague Buy 129 Rights to Common Stock Under BD Deferred Compensation Plan
2024-04-30 Garrison Michael David Sell 1 715 Common Stock
2024-04-04 Neal Shana Carol Sell 1 921 Common Stock
2024-03-14 Spoerel Thomas J Sell 282 Common Stock
INSIDER POWER
68.42
Last 100 transactions
Buy: 255 893 | Sell: 56 118

Forecast: 16:00 - $233.58

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $233.58
Forecast 2: 16:00 - $233.58
Forecast 3: 16:00 - $233.58
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $233.58 (-1.51% )
Volume 1.738 mill
Avg. Vol. 1.337 mill
% of Avg. Vol 129.99 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Becton Dickinson and Co

Last 12 Months

Last 12 months chart data with high, low, open and close for Becton Dickinson and Co

RSI

Intraday RSI14 chart for Becton Dickinson and Co

Last 10 Buy & Sell Signals For BDX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Becton Dickinson and Co

BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Last 10 Buy Signals

Date Signal @
SBUSXMay 9 - 08:11$19.67
INVUSDMay 9 - 08:2642.89
TIMEUSDMay 9 - 08:2032.09
GALXUSDMay 9 - 08:203.36
FTSEMIB.MIMay 9 - 08:0134 084
ZSUSXMay 9 - 08:041 228.25
ZLUSXMay 9 - 08:0443.66
ASRUSDMay 9 - 08:113.17
NULSUSDMay 9 - 08:10$0.641
GHSTUSDMay 9 - 08:08$1.723

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.